NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 181 filers reported holding NOVAVAX INC in Q1 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,039,000 | -68.5% | 811,777 | -69.0% | 0.00% | -100.0% |
| Q4 2016 | $3,300,000 | -36.6% | 2,619,021 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $5,203,000 | -68.2% | 2,619,021 | +16.5% | 0.00% | -75.0% |
| Q2 2016 | $16,344,000 | +40.9% | 2,248,096 | 0.0% | 0.01% | +33.3% |
| Q1 2016 | $11,600,000 | -38.5% | 2,248,096 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $18,862,000 | +18.7% | 2,248,096 | 0.0% | 0.01% | +12.5% |
| Q3 2015 | $15,894,000 | -36.5% | 2,248,096 | 0.0% | 0.01% | -38.5% |
| Q2 2015 | $25,044,000 | +51.6% | 2,248,096 | +12.5% | 0.01% | +62.5% |
| Q1 2015 | $16,524,000 | – | 1,998,096 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |